Cigarette smoking is associated with abnormal involuntary movements in the general male population - A study of men born in 1933

Biological Psychiatry

Volumn 41, Issue 6, 1997, Pages 717-723

  Nilsson, Agneta ^a,b   Waller, Lotte ^a   Rosengren, Annika ^a   Adlerberth, Annika ^a   Wilhelmsen, Lars ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b Karsudden Hospital   (Sweden)

Author keywords

dyskinesia; population study; smoking

Indexed keywords

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; HUMAN; INVOLUNTARY MOVEMENT; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; PARKINSONISM; PRIORITY JOURNAL; TARDIVE DYSKINESIA;

ALCOHOL DRINKING; ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; HEALTH; HUMANS; MALE; MENTAL DISORDERS; MIDDLE AGED; MODELS, PSYCHOLOGICAL; MOVEMENT DISORDERS; PARKINSON DISEASE; REGRESSION ANALYSIS; SMOKING;

EID: 0030948647     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00289-2     Document Type: Article

References (39)

1. Adler LA, Peselow E, Rotrosen J, et al (1993): Vitamin E treatment of tardive dyskinesia. Am J Psychiatry 150:1405-1407.
2. Andersson K, Fuxe K, Agnati LF (1981): Effects of single injection of nicotine on the ascending dopamine pathways in the rat. Evidence for increase of dopamine turnover in the mesostriatal and mesolimbic dopamine neurons. Acta Physiol Scand 112:345-347.
3. Bider RL, Kazamatsuri H, Nishimura T, McNeil DE (1987): Smoking and tardive dyskinesia. Biol Psychiatry 22:1280-1282.
4. Cadet JL, Lohr JB, Jeste DV (1986): Free radicals and tardive dyskinesia. Trends Neurosci 9:107-108.
5. Campbell RJ, Fann WE, Thornby JI (1983): Abnormal involuntary movements and chronic obstructive pulmonary disease. J Clin Psychopharmacol 3:179-182.
6. Casey DE (1987): Tardive dyskinesia. In Meltzer HY (ed), Psychopharmacology: The Third Generation of Progress. New York: Raven Press, pp 1411-1419.
7. Church DF, Pryor WA (1985): Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64:111-126.
8. Davis JM (1976): Comparative doses and costs of antipsychotic medication. Arch Gen Psychiatry 33:858-861.
9. Dilsaver SC, Smeltzer DJ (1988): Smoking and tardive dyskinesia. Biol Psychiatry 24:364.
10. Dixon L, Weiden PJ, Haas G, Sweeney J, Frances AJ (1992): Increased tardive dyskinesia in alcohol-abusing schizophrenic patients. Compr Psychiatry 33:121-122.
11. Egan MF, Hyde TM, Albers GW, Elkashef A, Alexander RC, Reeve A, et al (1992): Treatment of tardive dyskinesia with vitamin E. Am J Psychiatry 149:73-777.
12. Ganzini L, Heintz RT, Hoffman WF, Casey DE (1991): The prevalence of tardive dyskinesia in neuroleptic-treated diabetics. A controlled study. Arch Gen Psychiatry 48:259-263.
13. Gerlach J, Casey DE (1988): Tardive dyskinesia. Acta Psychiatr Scand 77:369-378.
14. Glazer WM, Morgenstern H, Niedzwiecki D, Hughes J (1988): Heterogeneity of tardive dyskinesia. A multivariate analysis. Br J Psychiatry 152:253-259.
15. Goff DC, Henderson DC, Amico E (1992): Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects. Am J Psychiatry 149:1189-1194.
16. Guy W (1976): ECDEU Assessment Manual for Psychopharmacology. U.S. Department of Health, Education, and Welfare. Washington, DC: U.S. Government Printing Office, pp 534-537.
17. Halliwell B, Gutteridge JMC (1985): Free radicals in biology and medicine. Oxford: Oxford University Press.
18. Horrobin DF, Glen AIM, Vaddadi KS (1994): The membrane hypothesis of schizophrenia. Schizophr Res 13:195-207.
19. Kane JM, Smith JM (1982): Tardive dyskinesia: Prevalence and risk factors, 1959-1979. Arch Gen Psychiatry 39:473-481.
20. Kane JM, Weinhold P, Kinon B, Wegner J, Leader M (1982): Prevalence of abnormal involuntary movements ("spontaneous dyskinesia") in the normal elderly. Psychopharmacology 77:105-108.
21. Kraepelin E (1971): Dementia Praecox and Paraphrenia (Barclay RM, Robertson GM, trans). New York: RE Krieger.
22. Lohr JB, Cadet JL, Lohr MA, et al (1988): Vitamin E in the treatment of tardive dyskinesia: The possible involvement of free radical mechanisms. Schizophr Bull 14:291-296.
23. McCreadie RG, Thara R, Kamath S, et al (1996): Abnormal movements in never-medicated Indian patients with schizophrenia. Br J Psychiatry 168:221-226.
24. Menza MA, Grossman N, Van Horn M, Cody R, Forman N (1991): Smoking and movement disorders in psychiatric patients. Biol Psychiatry 30:109-115.
25. Mukherjee S, Wisniewski A, Bilder R, Sackheim H (1985): Possible association between tardive dyskinesia and altered carbohydrate metabolism. Arch Gen Psychiatry 42:205.
26. Pall HS, Williams AC, Blake DR, Lunec J (1987): Evidence of enhanced lipid peroxiation in the cerebrospinal fluid of patients taking phenothiazines. Lancet ii:596-599.
27. Peet M, Laugharne J, Rangarajan N, Reynolds GP (1993): Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment. Int Clin Psychopharmacol 8:151-153.
28. Richardson MA, Pass R, Craig TJ, Vickers E (1984): Factors influencing the prevalence and severity of tardive dyskinesia. Psychopharmacol Bull 20:33-38.
29. Rosengren A, Wilhelmsen L, Eriksson E, Risberg B, Wedel H (1990): Lipoprotein (a) and coronary heart disease: A prospective case-control study in a general population sample of middle aged men. Br Med J 301:1248-1251.
30. Schooler N, Kane JM (1982): Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 39:486-487.
31. Shriqui CL, Bradwejn J, Annable L, Jones BD (1992): Vitamin E in the treatment of tardive dyskinesia: A double-blind placebo-controlled study. Am J Psychiatry 149:391-393.
32. Simpson GM, Angus JWS (1970): Drug-induced extrapyramidal disorder - A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:20-27.
33. Smith JM, Baldessarini RJ (1980): Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Arch Gen Psychiatry 37:1368-1373.
34. Waddington JL (1989): Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: The enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms. In Smythies JR, Bradley RJ (eds), International Review of Neurobiology, vol 31. San Diego: Academic Press, pp 297-353.
35. Waddington JL (1993): Schizophrenia: Developmental neuroscience and pathobiology. Lancet i:531-536.
36. Yassa R, Nair V, Schwartz G (1984): Tardive dyskinesia and the primary psychiatric diagnosis. Psychosomatics 25:135-138.
37. Yassa R, Samarthji L, Korpassy A, Ally J (1987): Nicotine exposure and tardive dyskinesia. Biol Psychiatry 22:67-72.
38. Yassa R (1988): Tardive dyskinesia and anticholinergic drugs. L'Encephale 14:233-239.
39. Ziedonis DM, Kosten TR, Glazer WM, Frances RJ (1994): Nicotine dependence and schizophrenia. Hosp Community Psychiatry 45:204-206.